Cipher Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cipher Capital’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$223K	Buy	+1,490	New	+$249K	0.1%	351

Other funds holding ALNY

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cipher Capital's ALNY Position: Q1 2024 in Review

Cipher Capital opened a new position in Alnylam Pharmaceuticals (ALNY) in Q1 2024: 1,490 shares worth $223K. The stake represents 0.1% of the portfolio and ranks #351 among its holdings.

498 funds tracked by Wall St. Rank hold ALNY as of Q1 2024.

Cipher Capital held 1,490 shares of Alnylam Pharmaceuticals worth $223K as of Q1 2024.
Alnylam Pharmaceuticals was a new Cipher Capital position in Q1 2024.
Alnylam Pharmaceuticals made up 0.1% of Cipher Capital's portfolio in Q1 2024, its #351 holding.
498 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.